Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT05229341
- Status
- Recruiting
Conditions
- Thyroid Gland Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Diagnostic Procedure — PROCEDUREAnalysis via DDMS-2
- Electronic Health Record Review — OTHERReview of medical records
- Needle Biopsy — PROCEDUREUndergo needle biopsy
Study Details
This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test for thyroid cancer. This test will use needle biopsies (small collections of tissue with a needle) from the thyroid to determine whether the participant has a malignant (cancer) or benign (not showing cancer) thyroid tumor. The information learned from this trial may help develop a more accurate test so that patients do not have unnecessary surgeries for nodules that are thought to be suspicious but are actually benign.
Key Dates
- Start date
- Oct 22, 2021
- Status verified
- Feb 2026
- Primary completion
- Oct 22, 2026
- Completion
- Oct 22, 2026
Study Design
- Enrollment
- 1,450 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Diagnostic (needle biopsy, DDMS-2)Patients undergo needle biopsy for collection of tissue samples. Tissue samples are analyzed using DDMS-2. Patients' medical records are also reviewed.
Primary Outcome Measure
Sensitivity of Diagnostic Deoxyribonucleic Acid (DNA) Methylation Signatures (DDMS-2) [ Time Frame: Up to 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | John H. Yim (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Duarte, CA
Related Studies
- Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid CancerRecruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersPHASE1 · Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic TherapyPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas